Page 5 - பரந்த நிறுவனம் ஆஃப் ஹார்வர்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rett Syndrome Research Trust Establishes Translational Medicine Advisory Board Share Article Four nationally prominent leaders in medical research join the board to advance progress toward a cure for Rett Syndrome “It is an honor to work with such distinguished colleagues on this advisory board; it is also a productive and very meaningful endeavor because of the intense commitment and unusually strong scientific sophistication of the Rett Syndrome Research Trust’s leadership,” said Dr. Hyman. TRUMBULL, Conn. (PRWEB) May 20, 2021 The Rett Syndrome Research Trust has established a Translational Medicine Advisory Board to provide new strategic direction for its CURE 360 agenda and open new avenues of innovative research that can be applied to Rett Syndrome. Four internationally recognized leaders in the field of medical research have joined the advisory board, all of whom have significant, broad academic and

United statesMonica coenraadsPhilip reillyStevene hymanPaul wangPaul nioiClinical development at seaside therapeuticsCore institute memberHarvard university provostClinical development at pfizerHead of medical research at autism speaksBoston university school of public healthStanley centerNational institute of mental healthBroad institute of harvardTranslational research at alnylam pharmaceuticals